FLT4 and neoplasm: In various experimental tumor models, overexpression of VEGF-C can induce lymphangiogenesis and disseminate metastatic tumor cells to lymph nodes [10], and the use of neutralizing antibodies against VEGF-C and VEGFR-3 can prevent tumor lymphangiogenesis and lymphatic metastasis [11].